Equity Overview
Price & Market Data
Price: $0.48
Daily Change: +$0.0213 / 4.44%
Daily Range: $0.45 - $0.52
Market Cap: $9,290,532
Daily Volume: 259,840
Performance Metrics
1 Week: 11.71%
1 Month: -20.15%
3 Months: -53.01%
6 Months: -30.82%
1 Year: -84.63%
YTD: -10.73%
Company Details
Employees: 6
Sector: Health technology
Industry: Medical specialties
Country:
Details
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.